SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001659617-19-000106
Filing Date
2019-07-15
Accepted
2019-07-15 16:22:57
Documents
1
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_156322215943382.html 4/A  
1 FORM 4/A wf-form4a_156322215943382.xml 4/A 4927
  Complete submission text file 0001659617-19-000106.txt   6288
Mailing Address 1415 WEST LOOP NORTH HOUSTON TX 77055
Business Address
KLEMP WALTER V (Reporting) CIK: 0000938419 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37758 | Film No.: 19955401

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations